Increases availability of cost-effective high-concentration low-volume adalimumab in Australia First approved biosimilar from the partnership with Cipla, which also includes four other biosimilar ...

Increases availability of cost-effective high-concentration low-volume adalimumab in Australia First approved biosimilar from the partnership with Cipla, which also includes four other biosimilar ...

Adalimumab-adbm injection, a biosimilar to Humira ® (adalimumab), has been made available by Boehringer Ingelheim. Adalimumab-adbm injection is an interchangeable biosimilar and can be substituted for ...

Increases availability of cost-effective high-concentration low-volume adalimumab in Australia First approved biosimilar from the partnership with Cipla, which also includes four other biosimilar ...

The price you pay for Humira (adalimumab) may depend on factors such as the form you take, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help ...

With nearly a dozen companies lined up with biosimilar versions of Humira, AbbVie is trying to figure out the lay of the land in 2023, the dreaded year that the company loses of exclusivity for the ...

Medically reviewed by Shadi Hamdeh, MDMedically reviewed by Shadi Hamdeh, MD Humira (adalimumab) side effects may include pain, irritation, swelling, or itching at the site of the injection, as well ...

SIMLANDI is the first high-concentration, citrate-free biosimilar to Humira that has been granted an interchangeability status by the FDA, and will qualify for interchangeable exclusivity for the 40mg ...